Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Follicular
×
olokizumab
×
Clear all
Filters
3
NCT03120949
2023-10-12
CREDO 4
R-Pharm
Phase 3
Completed
2,106 enrolled
30 charts